ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 27 of 44
Up
УЖМБС 2022, 7(3): 183–191
https://doi.org/10.26693/jmbs07.03.183
Clinical Medicine

Dynamics of Blood Lipid Profile Indicators in Patients with Acute Myocardial Infarction with Concomitant Type 2 Diabetes Mellitus Depending on the Chosen Treatment Tactics

Feldman D. A.
Abstract

The purpose of the study was to analyze the dynamics of lipid profile in patients with acute myocardial infarction with concomitant type 2 diabetes mellitus for 6 months of follow-up. Materials and methods. 120 patients took part in the study: group 1 – patients with acute myocardial infarction with type 2 diabetes mellitus (n = 70), group 2 – patients with acute myocardial infarction (n = 50). The control group included 20 healthy individuals. Depending on the tactics of treatment, 4 subgroups were formed depending on the tactics of treatment (coronary ventriculography with coronary artery stenting / standard anticoagulant therapy with dual antiplatelet therapy) and the presence or absence of type 2 diabetes mellitus. The diagnosis of "acute myocardial infarction" and "type 2 diabetes mellitus" was established in accordance with current orders of the Ministry of Health of Ukraine. All patients underwent laboratory and instrumental examinations on the first day of acute myocardial infarction and 6 months after it. The study was conducted in strict compliance with basic ethical principles. Statistical processing of the results of this study was performed using the software package StatSoft Inc. USA – "Statistica 6.0". Results and discussion. The average lipid profile on the first day of hospitalization in the examined groups was as follows: total cholesterol in patients of the 1st group was equal to 7.1 ± 1.05 mmol/L; 2nd – 5.45 ± 0.65 mmol/L; control – 2.47 ± 0.42 mmol/L; low-density lipoprotein cholesterol – 4.63 ± 1.07 mmol/L; 3.04 ± 0.65 mmol/L; 0.29 ± 0.32 mmol/L, respectively; low-density lipoprotein cholesterol – 0.64 ± 0.1 mmol/L; 0.47 ± 0.08 mmol/L; 0.24 ± 0.08 mmol/L, respectively; high-density lipoprotein cholesterol – 1.05 ± 0.21 mmol/L; 1.41 ± 0.18 mmol/L; 1.63 ± 0.16 mmol/L, respectively; triglyceride – 3.14 ± 0.48 mmol/L; 2.09 ± 0.57 mmol/L; 1.14 ± 0.39, respectively; atherogenic factor – 6.29 ± 2.92 mmol/L; 2.98 ± 0.86 mmol/L; 0.52 ± 0.21 mmol/L, respectively (p˂0.00001). These indicators were assessed separately for each of the four subgroups. In 6 months after bearing acute myocardial infarction the positive dynamics of indicators of a lipid profile was noted, but the tendency concerning worse indicators in the presence of type 2 diabetes mellitus remained. Patients who underwent coronary artery stenting during treatment compared with patients who received standard anticoagulant therapy with antiplatelet drugs, had a faster positive dynamics of lipid profile. Conclusion. Thus, in patients with comorbid pathology in the form of acute myocardial infarction with type 2 diabetes mellitus, there are high rates of atherogenic lipid fractions, high values of atherogenic factor against the background of low values of antiatherogenic lipid fractions, which has prognostic value in the course of the disease in relation to the progression of atherosclerotic vascular lesions. After coronary ventriculography, a faster positive dynamics of the above indicators was noted, which indicates the superiority of reperfusion methods of treatment over standard drugs

Keywords: acute myocardial infarction, type 2 diabetes mellitus, lipid profile indicators

Full text: PDF (Ukr) 286K

References
  1. Kіl'kіst' pomerlih za prichinami smertі u sіchnі 2022 roku [The number of deaths in January 2022]. 2022. [Ukrainian]. Available from: http://www.ukrstat.gov.ua
  2. Lin А, Kolossváry M, Cadet S, McElhinney P, Goeller M, Han D, et al. Radiomics-Based Precision Phenotyping Identifies Unstable Coronary Plaques From Computed Tomography Angiography. JACC Cardiovasc Imaging. 2022 May;15(5):859-871. PMID: 35512957. PMCID: PMC9072980. https://doi.org/10.1016/j.jcmg.2021.11.016
  3. Moise N, Friedman A. A mathematical model of immunomodulatory treatment in myocardial infarction. J Theor Biol. 2022;544:111122. PMID: 35427645. https://doi.org/10.1016/j.jtbi.2022.111122
  4. Schmitz T, Freuer D, Harmel E, Heier M, Peters A, Linseisen J, et al. Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction. Acta Diabetol. 2022 May 9. PMID: 35532812. https://doi.org/10.1007/s00592-022-01893-0.
  5. Mamadjanov Т, Volaklis K, Heier M, Freuer D, Amann U, Peters A, et al. Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry. BMJ Open. 2021;11(6):e046641. PMID: 34083341. PMCID: PMC8183232. https://doi.org/10.1136/bmjopen-2020-046641
  6. Pak S, Yatsynovich Y, Markovic JP. A meta-analysis on the correlation between admission hyperglycemia and myocardial infarct size on CMRI. Hellenic J Cardiol. 2018;59(3):174-178. PMID: 29024757. https://doi.org/10.1016/j.hjc.2017.09.009
  7. Gorb YG, Strona VI, Tkachenko OV. Rol' gemodinamіchnih і metabolіchnih chinnikіv u rozvitku ta progresuvannі hronіchnoї sercevoї nedostatnostі u hvorih z іshemіchnoyu hvoroboyu sercya ta cukrovim dіabetom 2 tipu [The role of hemodynamic and metabolic factors in the development and progression of chronic heart failure in patients with ischemic disease 2]. Ukr J Med Biol Sports. 2020;4(26):26-35. [Ukrainian]. https://doi.org/10.26693/JMBS05.04.026
  8. Zheng Y, Ley S, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. PMID: 29219149. https://doi.org/10.1038/nrendo.2017.151
  9. Shkala LV, Myshanich GI, Shkala OV, Cherpak OV, Karapetyan OA, Volkovska TG. Patogenetychni mekhanizmy ta oznaky sertsevo-sudynnykh urazhen pry tsukrovomu diabeti 2-go typu [Pathogenetic mechanisms and signs of cardiovascular lesions in type 2 diabetes mellitus]. Mizhnarodn endokryn zhurn. 2018;14(3):235-9. [Ukrainian]. https://doi.org/10.22141/2224-0721.14.3.2018.136418
  10. Zolotukhina YO. Fibrynolitychna aktyvnist krovi u patsiyentiv z ishemichnoyu khvoroboyu sertsya ta suputnim tsukrovym diabetom 2-go typu [Fibrinolytic activity of blood in patients with coronary heart disease and concomitant type 2 diabetes]. Ukr med chasopys. 2018;6(2):40-2. [Ukrainian]. https://doi.org/10.32471/umj.1680-3051.128.134557
  11. Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A, Miftaraj M. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407-18. PMID: 28402770. https://doi.org/10.1056/NEJMoa160866
  12. Mіnіsterstvo ohoroni zdorov’ya Ukraїni, Nakaz № 455. Unіfіkovanij klіnіchnij protokol ekstrenoї, pervinnoї, vtorinnoї (specіalіzovanoї) ta tretinnoї (visokospecіalіzovanoї) medichnoї dopomogi ta medichnoї reabіlіtacії «Gostrij koronarnij sindrom z elevacіeyu segmenta ST» [Unified clinical protocol of emergency, primary, secondary (specialized) and tertiary (highly specialized) medical care and medical rehabilitation "Acute coronary syndrome with elevation of the ST segment"]. K: Ministry of Health of Ukraine; 2014 July 2. p. 92. [Ukrainian]
  13. D'Onofrio N, Sardu C, Paolisso P, Minicucci F, Gragnano F, Ferraraccio F, et al. MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients. J Cell Physiol. 2020;235(2):1438-1452. PMID: 31294459. https://doi.org/10.1002/jcp.29064
  14. Kuryata AV, Bardachenko NI. Vliyanie srednih doz simvastatina na lipidnyj spektr krovi, uroven' sistemnogo vospaleniya v usloviyah vtorichnoj profilaktiki ishemicheskoj bolezni serdca [The effect of medium doses of simvastatin on the blood lipid spectrum, the level of systemic inflammation in conditions of secondary prevention of coronary heart disease]. Medicines of Ukraine. 2013;9-10(175-176):76-81. [Russian]
  15. Reiner Ž. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14(7):401-411. PMID: 28300080. https://doi.org/10.1038/nrcardio.2017.31
  16. Grabovska OI, Tatarchuk OM, Zavgorodnya N.Yu. Osoblivostі funkcіonal'noї aktivnostі іmunnoї sistemi, vuglevodnij і lіpіdnij obmіn u dіtej іz bіlіarnoyu dysfunkcіeyu na tlі nadmіrnoї masi tіla ta ozhirіnnya. [Features of functional activity of the immune system, carbohydrate and lipid metabolism in children with biliary dysfunction on the background of overweight and obesity]. Modern gastroenterology. 2021;5-6. [Ukrainian]. https://doi.org/10.30978/MG-2021-5-37
  17. Muntner P, Orroth KK, Mues KE, Exter J, Shannon ED, Zaha R, et al. Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease. Cardiovasc Drugs Ther. 2022;36(3):475-481. PMID: 33661432 PMCID: PMC8720507. https://doi.org/10.1007/s10557-021-07167-1
  18. Chang Z, Chen Y, Zhao Y, Fu L, Liu Y, Tang S, et al. Association of sunshine duration with acute myocardial infarction hospital admissions in Beijing, China: A time-series analysis within-summer. Sci Total Environ. 2022; 828:154528. PMID: 35292318. https://doi.org/10.1016/j.scitotenv.2022.154528